CCL2 and type 2 diabetes mellitus: ACEI were shown to inhibit LTA4 hydrolase (and consequently, LTB4 synthesis) [26], to reduce monocyte chemoattractant protein-1 expression in macrophages [27] and to decrease IL6 and tumor necrosis factor in normotensive type 2 diabetes individuals [28], among other effects.